Advertisement
Advertisement

DHR

DHR logo

Danaher Corporation

165.97
USD
Sponsored
-0.29
-0.18%
May 13, 16:00 UTC -4
Closed
exchange

After-Market

166.18

+0.21
+0.13%

Danaher Corporation Profile

About

Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of critical areas including genes, proteins, metabolites and cells to understand the causes of diseases, identify new therapies, and test new drugs and vaccines. Range of industries served includes biopharmaceutical, food and beverage, medical, aerospace, microelectronics, and general industrial. Diagnostics segment offers analytical instruments, reagents, consumables, software and services that are deployed in reference laboratories, hospitals, physicians' offices and other critical care settings. It helps to diagnose diseases and take suitable treatment decisions. Environmental & Applied Solutions segment offers products and services that help keep food and water supplies safe globally.

Info & Links

CEO

Rainer M. Blair

Headquarters

2200 PENNSYLVANIA AVENUE. N.W, SUITE 800W
WASHINGTON, DC 20037, UNITED STATES

Industry

Medical Services

Sector

Medical

Website

www.danaher.com

Auditor

Ernst & Young LLP

Share holders

1,985

Employees

60,000

Danaher Corporation Statistics

Valuation Measures

Market Capitalization2

117.61B

Enterprise Value

131.42B

Enterprise Value/EBITDA(ttm)

18.41

Price to Earnings Ratio(ttm)

24.74

Price to Sales(ttm)

5.56

Price to Book(mrq)

2.59

Price to Cash(ytd)

16.98

Profitability

Gross Margin(ttm)

59.18%

Operating Margin(ttm)

22.76%

Profit Margin(ttm)

14.62%

Return on Equity(ttm)

10.81%

Return on Invested Capital(ttm)

5.23%

Return on Assets(ttm)

6.90%

Income Statement

Revenue(ttm)

24.57B

Revenue Per Share(ttm)

34.74

Gross Profit(ttm)

14.52B

EBITDA(ttm)3

7.14B

Net Income Available to Common(ttm)

3.61B

Diluted EPS(ttm)

5.04

Share Statistics

Beta (5Y Monthly)

0.95

52-Week Change

-17.36%

S&P 500 52-Week Change

26.48%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

707.14M

Dividend Yield

0.83%

Float4

629.14M

% Held by Insiders

11.10%

% Held by Institutions

79.05%

Balance Sheet

Total Cash(mrq)

4.62B

Total Cash Per Share(mrq)

6.53

Total Debt(mrq)

18.42B

Total Debt/Equity(mrq)

35.05%

Current Ratio(mrq)

1.87%

Quick Ratio(mrq)

1.51%

Book Value Per Share(mrq)

74.33

Cash Flow

Operating Cash Flow Per Share(ytd)

8.96

Free Cash Flow(ytd)

5.29B

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement